Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

15 Jan 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · DIAGNOSTIC study · Breast Cancer · Enrollment 100 · Sponsor: UNC Lineberger Comprehensive Cancer Center

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 15 Jan 2026. The item focuses on Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer. Open the detail page to review the full original feed content.